GENE ONLINE|News &
Opinion
Blog

2019-09-10| InterviewsPolicy

Crowdsourcing, a Novel Data Sharing Strategy to Augment Patient Care: Interview with Dr. Alireza Haghighi at Harvard Medical School

by Rajaneesh K. Gopinath
Share To
Intensive research outcomes obtained using model organisms have certainly helped us take giant strides in mitigating life threatening diseases. Yet, it’s undeniable that they are imperfect substitutes for data obtained from humans. “We have been using models such as mice and zebrafish but there are big differences between these animals and humans. For a long time, we haven’t been paying enough attention to the importance of data even from a single patient” says Dr. Alireza Haghighi, Lead Clinical Molecular Geneticist of Harvard Brigham Genomic Medicine, an integrated clinical research program. He earnestly stressed how knowledge gained from a single individual could be a valuable resource in aiding the welfare of future patients.

It's free! Log in now to read

LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top